{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:04:36Z","timestamp":1792065876407,"version":"4.4.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81670555"],"award-info":[{"award-number":["81670555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81200307"],"award-info":[{"award-number":["81200307"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13578-017-0161-7","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T09:52:27Z","timestamp":1499161947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["The roles of microRNA families in hepatic fibrosis"],"prefix":"10.1186","volume":"7","author":[{"given":"Xue-Ping","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Bing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-Yan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Qiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang-Feng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"key":"161_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fphys.2015.00209","volume":"6","author":"J Lambrecht","year":"2015","unstructured":"Lambrecht J, et al. The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. Front Physiol. 2015;6:209.","journal-title":"Front Physiol"},{"key":"161_CR2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1742-4658.2010.07632.x","volume":"277","author":"X Jiang","year":"2010","unstructured":"Jiang X, et al. MicroRNAs and the regulation of fibrosis. FEBS J. 2010;277:2015\u201321.","journal-title":"FEBS J"},{"key":"161_CR3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3727\/105221615X14399878166078","volume":"16","author":"KY Teng","year":"2015","unstructured":"Teng KY, et al. Role of noncoding RNAs as biomarker and therapeutic targets for liver fibrosis. Gene Expr. 2015;16:155\u201362.","journal-title":"Gene Expr"},{"key":"161_CR4","first-page":"304","volume":"53","author":"AE Toosi","year":"2015","unstructured":"Toosi AE. Liver fibrosis: causes and methods of assessment. Rom J Intern Med. 2015;53:304\u201314.","journal-title":"Rom J Intern Med"},{"key":"161_CR5","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.metabol.2015.08.004","volume":"64","author":"JJ Yang","year":"2015","unstructured":"Yang JJ, et al. Non-coding RNA-mediated epigenetic regulation of liver fibrosis. Metabolism. 2015;64:1386\u201394.","journal-title":"Metabolism"},{"key":"161_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4103\/1319-3767.96445","volume":"18","author":"R Ahmad","year":"2012","unstructured":"Ahmad R, et al. Understanding the mechanism of hepatic fibrosis and potential therapeutic approaches. Saudi J Gastroenterol. 2012;18:155.","journal-title":"Saudi J Gastroenterol"},{"key":"161_CR7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/labinvest.2012.70","volume":"92","author":"M Kwiecinski","year":"2012","unstructured":"Kwiecinski M, et al. Expression of platelet-derived growth factor-C and insulin-like growth factor I in hepatic stellate cells is inhibited by miR-29. Lab Invest. 2012;92:978\u201387.","journal-title":"Lab Invest"},{"key":"161_CR8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphys.2012.00049","volume":"3","author":"A Noetel","year":"2012","unstructured":"Noetel A, et al. microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol. 2012;3:49.","journal-title":"Front Physiol"},{"key":"161_CR9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1152\/physiolgenomics.00141.2011","volume":"44","author":"AJ Kriegel","year":"2012","unstructured":"Kriegel AJ, et al. The miR-29 family: genomics, cell biology, and relevance to renal and cardiovascular injury. Physiol Genomics. 2012;44:237\u201344.","journal-title":"Physiol Genomics"},{"key":"161_CR10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","volume":"53","author":"C Roderburg","year":"2011","unstructured":"Roderburg C, et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology. 2011;53:209\u201318.","journal-title":"Hepatology"},{"key":"161_CR11","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1582-4934.2012.01578.x","volume":"16","author":"T Kogure","year":"2012","unstructured":"Kogure T, et al. Hepatic miR-29ab1 expression modulates chronic hepatic injury. J Cell Mol Med. 2012;16:2647\u201354.","journal-title":"J Cell Mol Med"},{"key":"161_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10735-013-9532-5","volume":"45","author":"J Hyun","year":"2014","unstructured":"Hyun J, et al. Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKK\u03b2-deficient mouse. J Mol Histol. 2014;45:103\u201312.","journal-title":"J Mol Histol"},{"key":"161_CR13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/cbf.3193","volume":"34","author":"C Liang","year":"2016","unstructured":"Liang C, et al. Suppressive effect of microRNA-29b on hepatic stellate cell activation and its crosstalk with TGF-\u03b21\/Smad3. Cell Biochem Funct. 2016;34:326\u201333.","journal-title":"Cell Biochem Funct"},{"key":"161_CR14","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.18632\/oncotarget.2621","volume":"6","author":"J Wang","year":"2015","unstructured":"Wang J, et al. microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway. Oncotarget. 2015;6:7325\u201338.","journal-title":"Oncotarget"},{"key":"161_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.bbrc.2009.11.056","volume":"391","author":"T Ogawa","year":"2010","unstructured":"Ogawa T, et al. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun. 2010;391:316\u201321.","journal-title":"Biochem Biophys Res Commun"},{"key":"161_CR16","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.bbrc.2014.03.037","volume":"446","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, et al. MiR-29b inhibits collagen maturation in hepatic stellate cells through down-regulating the expression of HSP47 and lysyl oxidase. Biochem Biophys Res Commun. 2014;446:940\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"161_CR17","doi-asserted-by":"crossref","first-page":"e0136453","DOI":"10.1371\/journal.pone.0136453","volume":"10","author":"YH Huang","year":"2015","unstructured":"Huang YH, et al. Activation of Mir-29a in activated hepatic stellate cells modulates its profibrogenic phenotype through inhibition of histone deacetylases 4. PLoS ONE. 2015;10:e0136453.","journal-title":"PLoS ONE"},{"key":"161_CR18","doi-asserted-by":"crossref","first-page":"e55786","DOI":"10.1371\/journal.pone.0055786","volume":"8","author":"I Mannaerts","year":"2013","unstructured":"Mannaerts I, et al. Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29. PLoS ONE. 2013;8:e55786.","journal-title":"PLoS ONE"},{"key":"161_CR19","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/onc.2013.216","volume":"33","author":"HJ Bae","year":"2014","unstructured":"Bae HJ, et al. MicroRNA-29c functions as a tumor suppressor by direct targeting oncogenic SIRT1 in hepatocellular carcinoma. Oncogene. 2014;33:2557\u201367.","journal-title":"Oncogene"},{"key":"161_CR20","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/j.1742-4658.2011.08075.x","volume":"278","author":"WQ Li","year":"2011","unstructured":"Li WQ, et al. The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J. 2011;278:1522\u201332.","journal-title":"FEBS J"},{"key":"161_CR21","doi-asserted-by":"crossref","first-page":"872","DOI":"10.18632\/oncotarget.1825","volume":"5","author":"M Agostini","year":"2014","unstructured":"Agostini M, et al. miR-34: from bench to bedside. Oncotarget. 2014;5:872\u201381.","journal-title":"Oncotarget"},{"key":"161_CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mrfmmm.2006.12.006","volume":"619","author":"IP Pogribny","year":"2007","unstructured":"Pogribny IP, et al. Induction of microRNAome deregulation in rat liver by long-term tamoxifen exposure. Mutat Res. 2007;619:30\u20137.","journal-title":"Mutat Res"},{"key":"161_CR23","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajpath.2012.06.010","volume":"181","author":"F Meng","year":"2012","unstructured":"Meng F, et al. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol. 2012;181:804\u201317.","journal-title":"Am J Pathol"},{"key":"161_CR24","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nature05939","volume":"447","author":"L He","year":"2007","unstructured":"He L, et al. A microRNA component of the p53 tumour suppressor network. Nature. 2007;447:1130\u20134.","journal-title":"Nature"},{"key":"161_CR25","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1152\/ajpendo.00112.2006","volume":"291","author":"HA Parkes","year":"2006","unstructured":"Parkes HA. Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo. Am J Physiol Endocrinol Metab. 2006;291:E737\u201344.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"161_CR26","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jhep.2008.11.025","volume":"50","author":"CJ Guo","year":"2009","unstructured":"Guo CJ, et al. miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol. 2009;50:766\u201378.","journal-title":"J Hepatol"},{"key":"161_CR27","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.12659\/MSM.894000","volume":"21","author":"G Yan","year":"2015","unstructured":"Yan G, et al. MicroRNA-34a promotes hepatic stellate cell activation via targeting ACSL1. Med Sci Monit. 2015;21:3008\u201315.","journal-title":"Med Sci Monit"},{"key":"161_CR28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/mmr.2014.2846","volume":"11","author":"X Li","year":"2015","unstructured":"Li X, et al. microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor \u03b3. Mol Med Rep. 2015;11:1017\u201324.","journal-title":"Mol Med Rep"},{"key":"161_CR29","doi-asserted-by":"crossref","first-page":"e2137","DOI":"10.1038\/cddis.2016.41","volume":"7","author":"L Tang","year":"2016","unstructured":"Tang L, et al. MiR-125a-5p decreases after long non-coding RNA HOTAIR knockdown to promote cancer cell apoptosis by releasing caspase 2. Cell Death Dis. 2016;7:e2137.","journal-title":"Cell Death Dis"},{"key":"161_CR30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","volume":"104","author":"AJ Tijsen","year":"2014","unstructured":"Tijsen AJ, et al. The microRNA-15 family inhibits the TGF\u03b2-pathway in the heart. Cardiovasc Res. 2014;104:61\u201371.","journal-title":"Cardiovasc Res"},{"key":"161_CR31","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbagrm.2011.05.005","volume":"1809","author":"ZM Zheng","year":"2011","unstructured":"Zheng ZM, et al. Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta. 2011;1809:668\u201377.","journal-title":"Biochim Biophys Acta"},{"key":"161_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00335-009-9240-3","volume":"21","author":"J Yue","year":"2010","unstructured":"Yue J, et al. Conservation of miR-15a\/16-1 and miR-15b\/16-2 clusters. Mamm Genome. 2010;21:88\u201394.","journal-title":"Mamm Genome"},{"key":"161_CR33","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1038\/srep12292","volume":"5","author":"D Santosa","year":"2015","unstructured":"Santosa D, et al. Hyperosmotic stress activates the expression of members of the miR-15\/107 family and induces downregulation of anti-apoptotic genes in rat liver. Sci Rep. 2015;5:12292.","journal-title":"Sci Rep"},{"key":"161_CR34","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1128\/JVI.02784-14","volume":"89","author":"N Liu","year":"2015","unstructured":"Liu N, et al. Hepatitis B virus regulates apoptosis and tumorigenesis through the microRNA-15a-Smad7-transforming growth factor beta pathway. J Virol. 2015;89:2739\u201349.","journal-title":"J Virol"},{"key":"161_CR35","doi-asserted-by":"crossref","first-page":"e62965","DOI":"10.1371\/journal.pone.0062965","volume":"8","author":"E Fognani","year":"2013","unstructured":"Fognani E, et al. Role of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemia. PLoS ONE. 2013;8:e62965.","journal-title":"PLoS ONE"},{"key":"161_CR36","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00705-015-2474-3","volume":"160","author":"B Zhu","year":"2015","unstructured":"Zhu B, et al. Increased miR-16 expression induced by hepatitis C virus infection promotes liver fibrosis through downregulation of hepatocyte growth factor and Smad7. Arch Virol. 2015;160:2043\u201350.","journal-title":"Arch Virol"},{"key":"161_CR37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.clinimag.2012.02.017","volume":"37","author":"Z Jiang","year":"2013","unstructured":"Jiang Z, et al. Attenuation of hepatic fibrosis through ultrasound-microbubble-mediated HGF gene transfer in rats. Clin Imaging. 2013;37:104\u201310.","journal-title":"Clin Imaging"},{"key":"161_CR38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0002-9440(10)62323-1","volume":"166","author":"WH Kim","year":"2005","unstructured":"Kim WH, et al. Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis. Am J Pathol. 2005;166:1017\u201328.","journal-title":"Am J Pathol"},{"key":"161_CR39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.mito.2012.05.001","volume":"13","author":"S Fulda","year":"2013","unstructured":"Fulda S. Modulation of mitochondrial apoptosis by PI3K inhibitors. Mitochondrion. 2013;13:195\u20138.","journal-title":"Mitochondrion"},{"key":"161_CR40","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s10495-009-0401-3","volume":"14","author":"CJ Guo","year":"2009","unstructured":"Guo CJ, et al. Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis. 2009;14:1331\u201340.","journal-title":"Apoptosis"},{"key":"161_CR41","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1742-1241.2004.00284.x","volume":"58","author":"CH Golias","year":"2004","unstructured":"Golias CH, et al. Cell proliferation and cell cycle control: a mini review. Int J Clin Pract. 2004;58:1134\u201341.","journal-title":"Int J Clin Pract"},{"key":"161_CR42","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1002\/jcp.22598","volume":"226","author":"Y Sekiya","year":"2011","unstructured":"Sekiya Y, et al. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-\u03b2-induced inhibition of hepatic stellate cell proliferation. J Cell Physiol. 2011;226:2535\u201342.","journal-title":"J Cell Physiol"},{"key":"161_CR43","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1515\/bmc-2016-0020","volume":"7","author":"D Senfter","year":"2016","unstructured":"Senfter D, et al. The microRNA-200 family: still much to discover. Biomol Concepts. 2016;7:311\u20139.","journal-title":"Biomol Concepts."},{"key":"161_CR44","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1074\/jbc.M113.529172","volume":"289","author":"N Kolesnikoff","year":"2014","unstructured":"Kolesnikoff N, et al. Specificity protein 1 (Sp1) maintains basal epithelial expression of the miR-200 family: implications for epithelial-mesenchymal transition. J Biol Chem. 2014;289:11194\u2013205.","journal-title":"J Biol Chem"},{"key":"161_CR45","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fphys.2015.00050","volume":"6","author":"AC Chung","year":"2015","unstructured":"Chung AC, et al. microRNAs in renal fibrosis. Front Physiol. 2015;6:50.","journal-title":"Front Physiol"},{"key":"161_CR46","doi-asserted-by":"crossref","first-page":"e13614","DOI":"10.1371\/journal.pone.0013614","volume":"5","author":"S Oba","year":"2010","unstructured":"Oba S, et al. miR-200b precursor can ameliorate renal tubulointerstitial fibrosis. PLoS ONE. 2010;5:e13614.","journal-title":"PLoS ONE"},{"key":"161_CR47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3892\/ijmm.2012.894","volume":"29","author":"Y Chen","year":"2012","unstructured":"Chen Y, et al. miR-200b is involved in intestinal fibrosis of Crohn\u2019s disease. Int J Mol Med. 2012;29:601\u20136.","journal-title":"Int J Mol Med"},{"key":"161_CR48","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/labinvest.2010.113","volume":"90","author":"IP Pogribny","year":"2010","unstructured":"Pogribny IP, et al. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab Invest. 2010;90:1437\u201346.","journal-title":"Lab Invest"},{"key":"161_CR49","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2014.10.033","volume":"62","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, et al. Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6\/STAT3 signalling. J Hepatol. 2015;62:889\u201396.","journal-title":"J Hepatol"},{"key":"161_CR50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11010-013-1895-0","volume":"388","author":"X Sun","year":"2014","unstructured":"Sun X, et al. Participation of miR-200a in TGF-\u03b21-mediated hepatic stellate cell activation. Mol Cell Biochem. 2014;388:11\u201323.","journal-title":"Mol Cell Biochem"},{"key":"161_CR51","doi-asserted-by":"crossref","first-page":"G39","DOI":"10.1152\/ajpgi.00263.2007","volume":"294","author":"JH Cheng","year":"2008","unstructured":"Cheng JH, et al. Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2008;294:G39\u201349.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"161_CR52","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1016\/j.cellsig.2014.07.016","volume":"26","author":"JJ Yang","year":"2014","unstructured":"Yang JJ, et al. MicroRNA-200a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cell Signal. 2014;26:2381\u20139.","journal-title":"Cell Signal"},{"key":"161_CR53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fonc.2012.00200","volume":"2","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi Y, et al. The Keap1\u2013Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol. 2012;2:200.","journal-title":"Front Oncol."},{"key":"161_CR54","doi-asserted-by":"crossref","first-page":"e70744","DOI":"10.1371\/journal.pone.0070744","volume":"8","author":"S Ramachandran","year":"2013","unstructured":"Ramachandran S, et al. Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS ONE. 2013;8:e70744.","journal-title":"PLoS ONE"},{"key":"161_CR55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/cvr\/cvw052","volume":"110","author":"Z Li","year":"2016","unstructured":"Li Z, et al. miR-199-sponge transgenic mice develop physiological cardiac hypertrophy. Cardiovasc Res. 2016;110:258\u201367.","journal-title":"Cardiovasc Res"},{"key":"161_CR56","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.0812446106","volume":"106","author":"LM Friedman","year":"2009","unstructured":"Friedman LM, et al. MicroRNAs are essential for development and function of inner ear hair cells in vertebrates. Proc Natl Acad Sci USA. 2009;106:7915\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"key":"161_CR57","doi-asserted-by":"crossref","first-page":"43409","DOI":"10.1038\/srep43409","volume":"7","author":"R Yang","year":"2017","unstructured":"Yang R, et al. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO. Sci Rep. 2017;7:43409.","journal-title":"Sci Rep"},{"key":"161_CR58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/ki.2010.154","volume":"78","author":"M Pang","year":"2010","unstructured":"Pang M, et al. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy. Kidney Int. 2010;78:257\u201368.","journal-title":"Kidney Int"},{"key":"161_CR59","first-page":"24","volume":"4","author":"S Roy","year":"2015","unstructured":"Roy S, et al. The role of miRNAs in the regulation of inflammatory processes during hepatofibrogenesis. Hepatobiliary Surg Nutr. 2015;4:24\u201333.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"161_CR60","doi-asserted-by":"crossref","first-page":"e16081","DOI":"10.1371\/journal.pone.0016081","volume":"6","author":"Y Murakami","year":"2011","unstructured":"Murakami Y, et al. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE. 2011;6:e16081.","journal-title":"PLoS ONE"},{"key":"161_CR61","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1091\/mbc.E13-01-0017","volume":"24","author":"O Mungunsukh","year":"2013","unstructured":"Mungunsukh O, et al. Transforming growth factor-\u03b21 selectively inhibits hepatocyte growth factor expression via a micro-RNA-199-dependent posttranscriptional mechanism. Mol Biol Cell. 2013;24:2088\u201397.","journal-title":"Mol Biol Cell"},{"key":"161_CR62","doi-asserted-by":"crossref","first-page":"e1003291","DOI":"10.1371\/journal.pgen.1003291","volume":"9","author":"CL Lino Cardenas","year":"2013","unstructured":"Lino Cardenas CL, et al. miR-199a-5p Is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 2013;9:e1003291.","journal-title":"PLoS Genet"},{"key":"161_CR63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13075-016-0929-x","volume":"18","author":"S O\u2019Reilly","year":"2016","unstructured":"O\u2019Reilly S. MicroRNAs in fibrosis: opportunities and challenges. Arthritis Res Ther. 2016;18:11.","journal-title":"Arthritis Res Ther"},{"key":"161_CR64","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1074\/jbc.M008340200","volume":"276","author":"B Razani","year":"2001","unstructured":"Razani B, et al. Caveolin-1 regulates transforming growth factor (TGF)-beta\/SMAD signaling through an interaction with the TGF-beta type I receptor. J Biol Chem. 2001;276:6727\u201338.","journal-title":"J Biol Chem"},{"key":"161_CR65","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1186\/1471-2407-14-880","volume":"14","author":"F Megiorni","year":"2014","unstructured":"Megiorni F, et al. Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. BMC Cancer. 2014;14:880.","journal-title":"BMC Cancer"},{"key":"161_CR66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/hep.26222","volume":"57","author":"E Bellafante","year":"2013","unstructured":"Bellafante E, et al. Hepatic-specific activation of peroxisome proliferator-activated receptor \u03b3 coactivator-1\u03b2 protects against steatohepatitis. Hepatology. 2013;57:1343\u201356.","journal-title":"Hepatology"},{"key":"161_CR67","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.biocel.2010.10.015","volume":"43","author":"SS Choi","year":"2011","unstructured":"Choi SS, et al. The role of Hedgehog signaling in fibrogenic liver repair. Int J Biochem Cell Biol. 2011;43:238\u201344.","journal-title":"Int J Biochem Cell Biol"},{"key":"161_CR68","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1038\/ncomms10993","volume":"7","author":"J Hyun","year":"2016","unstructured":"Hyun J, et al. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun. 2016;7:10993.","journal-title":"Nat Commun"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-017-0161-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T11:15:52Z","timestamp":1569669352000},"score":1,"resource":{"primary":{"URL":"http:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-017-0161-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,4]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1186\/s13578-017-0161-7","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,4]]},"article-number":"34"}}